Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Postdischarge Glucocorticoid Use and Clinical Outcomes of Multisystem Inflammatory Syndrome in Children.
Son MBF, Berbert L, Young C, Dallas J, Newhams M, Chen S, Ardoin SP, Basiaga ML, Canny SP, Crandall H, Dhakal S, Dhanrajani A, Sagcal-Gironella ACP, Hobbs CV, Huie L, James K, Jones M, Kim S, Lionetti G, Mannion ML, Muscal E, Prahalad S, Schulert GS, Tejtel KS, Villacis-Nunez DS, Wu EY, Zambrano LD, Campbell AP, Patel MM, Randolph AG; Overcoming COVID-19 Investigators. Son MBF, et al. Among authors: dhanrajani a. JAMA Netw Open. 2022 Nov 1;5(11):e2241622. doi: 10.1001/jamanetworkopen.2022.41622. JAMA Netw Open. 2022. PMID: 36367723 Free PMC article.
Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021.
Zambrano LD, Newhams MM, Olson SM, Halasa NB, Price AM, Boom JA, Sahni LC, Kamidani S, Tarquinio KM, Maddux AB, Heidemann SM, Bhumbra SS, Bline KE, Nofziger RA, Hobbs CV, Bradford TT, Cvijanovich NZ, Irby K, Mack EH, Cullimore ML, Pannaraj PS, Kong M, Walker TC, Gertz SJ, Michelson KN, Cameron MA, Chiotos K, Maamari M, Schuster JE, Orzel AO, Patel MM, Campbell AP, Randolph AG; Overcoming COVID-19 Investigators. Zambrano LD, et al. MMWR Morb Mortal Wkly Rep. 2022 Jan 14;71(2):52-58. doi: 10.15585/mmwr.mm7102e1. MMWR Morb Mortal Wkly Rep. 2022. PMID: 35025852 Free PMC article.
Active Surveillance With Seroprevalence-based Infection Rates Indicates Racial Disparities With Pediatric SARS-CoV-2 Requiring Hospitalization in Mississippi, March 2020-February 2021.
Hobbs CV, Kim SS, Vemula P, Inagaki K, Harrison VA, Malloch L, Martin LM, Singh G, Agana U, Williams JM, Patterson K, Kittle T, Byers P, Palmer A, Santos RP, Dhanrajani A, Stephenson M, Hung L, Hankins P, Thornburg N, Drobeniuc J, Flannery B; CDC COVID-19 Response Team. Hobbs CV, et al. Among authors: dhanrajani a. Pediatr Infect Dis J. 2022 Sep 1;41(9):736-741. doi: 10.1097/INF.0000000000003593. Epub 2022 Jun 7. Pediatr Infect Dis J. 2022. PMID: 35703309 Free PMC article.
Life-Threatening Complications of Influenza vs Coronavirus Disease 2019 (COVID-19) in US Children.
Halasa NB, Spieker AJ, Young CC, Olson SM, Newhams MM, Amarin JZ, Moffitt KL, Nakamura MM, Levy ER, Soma VL, Talj R, Weiss SL, Fitzgerald JC, Mack EH, Maddux AB, Schuster JE, Coates BM, Hall MW, Schwartz SP, Schwarz AJ, Kong M, Spinella PC, Loftis LL, McLaughlin GE, Hobbs CV, Rowan CM, Bembea MM, Nofziger RA, Babbitt CJ, Bowens C, Flori HR, Gertz SJ, Zinter MS, Giuliano JS, Hume JR, Cvijanovich NZ, Singh AR, Crandall HA, Thomas NJ, Cullimore ML, Patel MM, Randolph AG; Pediatric Intensive Care Influenza; Overcoming COVID-19 Investigators. Halasa NB, et al. Clin Infect Dis. 2023 Feb 8;76(3):e280-e290. doi: 10.1093/cid/ciac477. Clin Infect Dis. 2023. PMID: 35717646 Free PMC article.
Risk factors for health impairments in children after hospitalization for acute COVID-19 or MIS-C.
Maddux AB, Young CC, Kucukak S, Zambrano LD, Newhams MM, Rollins CK, Halasa NB, Gertz SJ, Mack EH, Schwartz S, Kong M, Loftis LL, Irby K, Rowan CM, Tarquinio KM, Zinter MS, Crandall H, Cvijanovich NZ, Schuster JE, Fitzgerald JC, Staat MA, Hobbs CV, Nofziger RA, Shein S, Flori H, Cullimore ML, Chatani BM, Levy ER, Typpo KV, Hume JR, Campbell AP, Randolph AG; Overcoming COVID-19 Investigators. Maddux AB, et al. Front Pediatr. 2023 Oct 18;11:1260372. doi: 10.3389/fped.2023.1260372. eCollection 2023. Front Pediatr. 2023. PMID: 37920792 Free PMC article.
Comparative Effectiveness of a Second Tumor Necrosis Factor Inhibitor Versus a Non-Tumor Necrosis Factor Biologic in the Treatment of Patients With Polyarticular-Course Juvenile Idiopathic Arthritis.
Mannion ML, Amin S, Balevic S, Chang ML, Correll CK, Kearsley-Fleet L, Hyrich KL, Beukelman T; Childhood Arthritis and Rheumatology Research Alliance Registry Investigators and the UK Juvenile Idiopathic Arthritis Biologics Register Investigators. Mannion ML, et al. Arthritis Care Res (Hoboken). 2024 Mar 31. doi: 10.1002/acr.25339. Online ahead of print. Arthritis Care Res (Hoboken). 2024. PMID: 38556945
Aspirin Dose in Kawasaki Disease: The Ongoing Battle.
Dhanrajani A, Chan M, Pau S, Ellsworth J, Petty R, Guzman J. Dhanrajani A, et al. Arthritis Care Res (Hoboken). 2018 Oct;70(10):1536-1540. doi: 10.1002/acr.23504. Epub 2018 Sep 7. Arthritis Care Res (Hoboken). 2018. PMID: 29287309
16 results